Additional oncological benefit of photodynamic diagnosis with blue light cystoscopy in transurethral resection for primary non‐muscle‐invasive bladder cancer: A comparative study from experienced institutes

Author:

Miyake Makito1ORCID,Nishimura Nobutaka1,Nakahama Tomonori1,Nishimoto Koshiro2,Oyama Masafumi2ORCID,Matsushita Yuto3,Miyake Hideaki3,Fukuhara Hideo4ORCID,Inoue Keiji4,Kobayashi Keita5,Matsumoto Hiroaki5,Matsuyama Hideyasu5,Fujii Tomomi6,Hirao Yoshihiko7,Fujimoto Kiyohide1ORCID

Affiliation:

1. Department of Urology Nara Medical University Kashihara Nara Japan

2. Department of Uro‐Oncology Saitama Medical University International Medical Center Hidaka Saitama Japan

3. Department of Urology Hamamatsu University School of Medicine Hamamatsu Shizuoka Japan

4. Department of Urology Kochi Medical School Nankoku Kochi Japan

5. Department of Urology, Graduate School of Medicine Yamaguchi University Ube Yamaguchi Japan

6. Department of Diagnostic Pathology Nara Medical University Kashihara Nara Japan

7. Department of Urology Osaka Gyoumeikan Hospital Konohana‐ku Osaka Japan

Abstract

AbstractObjectivesThe objective of this work is to evaluate the additional oncological benefit of photodynamic diagnosis (PDD) using blue‐light cystoscopy in transurethral resection (TURBT) for primary non‐muscle‐invasive bladder cancer (NMIBC) based on the International Bladder Cancer Group (IBCG)‐defined progression and the subsequent pathological pathways.Patients and MethodsWe reviewed 1578 consecutive primary NMIBC patients undergoing white‐light TURBT (WL‐TURBT) or PDD‐TURBT during 2006–2020. One‐to‐one propensity score‐matching was performed using multivariable logistic regression to obtain balanced groups. IBCG‐defined progression of NMIBC included stage‐up and grade‐up as well as conventional definitions such as the development of muscle‐invasive BC or metastatic disease. Nine oncological endpoints were evaluated. Sankey diagrams were generated to visualize follow‐up pathological pathways after the initial TURBT.ResultsComparison of event‐free survival between the matched groups revealed that PDD use decreased the bladder cancer recurrence risk and IBCG‐defined progression risk, whereas no significant difference was noted in conventionally defined progression. This was attributable to a reduced risk of stage‐up, from Ta to T1, and grade‐up. Sankey diagrams of the matched groups showed that patients with primary Ta low‐grade tumour and first‐recurrence Ta low‐grade tumour did not have bladder recurrence or progression, while some of those in the WL‐TURBT group developed recurrence after treatment.ConclusionsThe multiple survival analysis demonstrated that the risk of IBCG‐defined progression was significantly decreased by PDD use in NMIBC patients. Sankey diagrams revealed possible differences in pathological pathways after the initial TURBT between the two groups, demonstrating that repeated recurrence could be prevented by PDD use.

Publisher

Wiley

Subject

Religious studies,Cultural Studies

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3